Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-11
DOI
10.1007/s12016-022-08922-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan
- (2021) Jung-Lung Hsu et al. Scientific Reports
- Dermatomyositis autoantibodies: how can we maximize utility?
- (2021) Luqman Mushila Hodgkinson et al. Annals of Translational Medicine
- Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
- (2021) Urmi Khanna et al. Annals of Translational Medicine
- Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis‐specific autoantibodies
- (2021) Maria Casal‐Dominguez et al. Arthritis & Rheumatology
- Dermatomyositis: An Update on Diagnosis and Treatment
- (2020) Gabriela A. Cobos et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Clinical significance of serum levels of anti‐transcriptional intermediary factor 1‐γ antibody in patients with dermatomyositis
- (2020) Nobuaki Ikeda et al. JOURNAL OF DERMATOLOGY
- The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants
- (2020) Dario Didona et al. EUROPEAN JOURNAL OF DERMATOLOGY
- Risk Factors and Cancer Screening in Myositis
- (2020) Siamak Moghadam-Kia et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- TIF1 Proteins in Genome Stability and Cancer
- (2020) Roisin M. McAvera et al. Cancers
- Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
- (2019) Z. Betteridge et al. JOURNAL OF AUTOIMMUNITY
- Dermatomyositis Part I: Clinical Features and Pathogenesis
- (2019) Madeline E. DeWane et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen
- (2019) Julie De Vooght et al. RHEUMATOLOGY
- Dermatomyositis: Current concepts
- (2018) Ivan Bogdanov et al. CLINICS IN DERMATOLOGY
- Antinuclear antibodies and cancer: A literature review
- (2018) Alexandru Vlagea et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evidence supports blind screening for internal malignancy in dermatomyositis
- (2018) Hayley Leatham et al. MEDICINE
- Autoantibodies in myositis
- (2018) Neil J. McHugh et al. Nature Reviews Rheumatology
- Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies
- (2018) Paige W. Wolstencroft et al. Current Rheumatology Reports
- The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis
- (2018) Alexander Oldroyd et al. RHEUMATOLOGY
- Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
- (2017) Sarah L. Tansley et al. JOURNAL OF AUTOIMMUNITY
- High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset
- (2017) Maria Casal-Dominguez et al. MUSCLE & NERVE
- Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients
- (2017) Anna Rogers et al. ARTHRITIS CARE & RESEARCH
- Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients
- (2017) Jemima Albayda et al. ARTHRITIS CARE & RESEARCH
- Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis
- (2016) Angela Ceribelli et al. CLINICAL RHEUMATOLOGY
- Risk of Malignancy in Dermatomyositis and Polymyositis
- (2016) Judy K. Qiang et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies
- (2015) Jeannette M. Olazagasti et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Amyophatic dermatomyositis presenting as a flagellated skin eruption with positiveMDA5antibodies and thyroid cancer: a real association?
- (2015) A. M. Molina-Ruiz et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
- (2015) Minoru Satoh et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
- (2015) Z. Betteridge et al. JOURNAL OF INTERNAL MEDICINE
- Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
- (2015) David F. Fiorentino et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy
- (2015) Vidya Limaye et al. MUSCLE & NERVE
- High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis: Table 1
- (2015) Yoshinao Muro et al. RHEUMATOLOGY
- Review: Cancer-Induced Autoimmunity in the Rheumatic Diseases
- (2015) Ami A. Shah et al. Arthritis & Rheumatology
- Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
- (2013) David F. Fiorentino et al. ARTHRITIS AND RHEUMATISM
- Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
- (2013) Yasuhito Hamaguchi et al. PLoS One
- Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
- (2012) Yuki Ichimura et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
- (2012) Manabu Fujimoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort
- (2012) Elena Tarricone et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Morbidity and Mortality in Adult Polymyositis and Dermatomyositis
- (2012) Isabelle Marie Current Rheumatology Reports
- Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
- (2011) Manabu Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update
- (2010) Paula Morris et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein
- (2009) G. ESPADA et al. JOURNAL OF RHEUMATOLOGY
- Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis
- (2008) Z E Betteridge et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started